Close Menu

NEW YORK – Hologic said after the close of the market on Wednesday that its revenues for the fiscal third quarter fell nearly 4 percent year over year. The reason for the decline was the inclusion of revenue from its divested Cynosure Medical Aesthetics business in the year-ago quarter.

Hologic posted $822.9 million in total revenues for the quarter, compared to $852.4 million in the year-ago period. It handily beat the consensus Wall Street revenue estimate of $616.7 million. Excluding material acquisitions and divestitures, organic revenue grew nearly 8 percent in the quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Pfizer and BioNTech announce they are seeking FDA authorization for their candidate SARS-CoV-2 vaccine.

Science has retracted a 2007 paper from a former Dutch minister and his colleagues, according to Retraction Watch.

The New York Times reports that a plan to cull minks in Denmark to prevent the spread of a new SARS-CoV-2 strain led to calls for the prime minister's resignation.

In Science this week: winner of the Science & SciLifeLab Prize for Young Scientists, and more.